USPTO Implements Climate Change Mitigation Pilot Program

By Donald Zuhn — In a notice published last week in the Federal Register (87 Fed. Reg. 33750), the US Patent and Trademark Office announced the implementation of the Climate Change Mitigation Pilot Program, “which is designed to positively impact the climate by accelerating the examination of patent applications for innovations that reduce greenhouse gas … Read more

Opinion | Congress Must Rein In Skyrocketing Drug Prices

Millions of Americans are forced to ration or go without prescription drugs because of their high cost. Yet Congress has so far failed to pass legislation to lower drug prices. They may have another shot. Drug pricing reforms passed by the House of Representatives last November stalled after Senator Joe Manchin of West Virginia withdrew … Read more

Enhertu Breast Cancer Drug Results in ‘Unheard-of’ Survival Rates

The patients had metastatic breast cancer that had been progressing despite rounds of harsh chemotherapy. But a treatment with a drug that targeted cancer cells with laserlike precision was stunningly successful, slowing tumor growth and extending life to an extent seen with advanced cancers. The new study, presented at the annual meeting of the American … Read more

After losing her daughter to a rare disease, Sharon King is looking to rewrite the playbook of drug development

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. “Hope requires action,” Sharon King is fond of saying. And her daughter, Taylor, knew all about action. Sharon King, manager of advocacy and community engagement, Aldevron Permission granted by Sharon King. Taylor was 10 years old when … Read more

Pharma giants take on Appalachian cancer rates in newest screening initiative

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Two portraits, or perhaps stereotypes, of rural Appalachia exist. One conjures images of winding country roads connecting idyllic Leave-It-To-Beaver towns hidden in the shadows of rugged mountain ranges. The other brings to mind rusted suspension bridges, buckling … Read more

First 90 Days: Janssen Immunology’s David Jimenez

Listen to the article 8 min This audio is auto-generated. Please let us know if you have feedback. Staying at one company for decades isn’t for everyone. But during his 22-plus-year career at Johnson & Johnson, David Jimenez has always stayed on his toes β€” moving between different business units on four different continents in … Read more

A Cancer Trial’s Unexpected Result: Remission in Every Patient

It was a small trial, just 18 rectal cancer patients, every one of whom took the same drug. But the results were astonishing. The cancer vanished in every single patient, undetectable by physical exam, endoscopy, PET scans or MRI scans. Dr. Luis A. Diaz Jr. of Memorial Sloan Kettering Cancer Center, an author of a … Read more

Flagship’s creative approach to finding the next big idea in biopharma

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. The first rule of improv is to agree and say β€œyes.” Saying “no” during a scene crashes it to a halt. But saying yes opens a whole world of possibilities, and with the right imagination, you’ll go … Read more

Aduhelm’s Medicare woes leave questions about lofty premiums

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. The approval of Biogen’s Aduhelm continues to have ripple effects across healthcare. Most recently, it’s rattled the payer landscape for Medicare, potentially triggering longer-term changes to how the government approaches payments for high-cost drugs. Last Friday, the … Read more